Koya Medical Revenue and Competitors

Location

#413

Growjo Ranking

Estimated Revenue & Valuation

  • Koya Medical's estimated annual revenue is currently $28.1M per year.(i)
  • Koya Medical's estimated revenue per employee is $251,000
  • Koya Medical's total funding is $37M.

Employee Data

  • Koya Medical has 112 Employees.(i)
  • Koya Medical grew their employee count by 58% last year.

Koya Medical's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
CMOReveal Email/Phone
3
VP, Operations & TechnologyReveal Email/Phone
4
VP SalesReveal Email/Phone
5
Director, Manufacturing OperationsReveal Email/Phone
6
Clinical Research Associate ConsultantReveal Email/Phone
7
Product SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Koya Medical?

Koya Medical is a transformative healthcare venture with a mission to treat cancer-related chronic lymphedema and venous diseases through innovative patient-centric platforms. We are proudly located in Oakland, California where we design, develop and manufacture our products. Interested in joining our team? Contact careeers@koyamedical.com

keywords:N/A

$37M

Total Funding

112

Number of Employees

$28.1M

Revenue (est)

58%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Koya Medical News

2022-04-17 - Koya Medical launches Dayspring active compression treatments

Koya Medical launches Dayspring lower extremity active compression treatments for lymphoedema and venous disorders. 19th April 2022. 163. Koya Medical...

2022-04-13 - Koya Medical Launches Dayspring® Lower Extremity Active ...

--(BUSINESS WIRE)--Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of...

2021-09-28 - Koya Medical : Receives FDA Clearance for Dayspring Lite, Bringing Much-Needed Movement to People Beginning Compression Therapy to Treat Lymphedema and Venous Disease

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, received Food and Drug Administration (FDA) 510(k) clearance for its Dayspring® Lite treatment for lymphedema and venous disease. Unlike t ...

2021-08-10 - Koya Medical : Secures First Reimbursement Codes for Dayspring, for Lymphedema; Publishes Clinical Data Demonstrating Improved Function, Appearance, Mood and Symptoms

Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active compression therapy system for lymphedema—Dayspring™— was issued new billing codes by the Center of Medicare & Medicaid Services (CMS) in ...

2021-05-26 - Koya Medical Receives FDA Clearance for Indication of First Mobility-Enabled Active Compression for Lower Extremities

OAKLAND, Calif., May 26, 2021 /PRNewswire/ -- Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that it has received Food and Drug Administration (FDA) 510(k) clearance for its active compression therapy system ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$32.5M1129%N/A
#2
$3.5M11244%N/A
#3
$23.5M1129%N/A
#4
$35M1146%N/A
#5
$37.1M1156%N/A